Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Apr 01, 2022Apr 05, 2022Paul Steven M
Dir
SellAlnylam Pharmaceuticals, Inc.ALNY$170.69$3M-93.75%
Aug 17, 2021Aug 18, 2021Paul Steven M
Pres
amp; CEO
BuyKaruna Therapeutics, Inc.KRTX$105.87$250,264+2.13%
Dec 18, 2020Dec 22, 2020Paul Steven M
Dir
SellAlnylam Pharmaceuticals, Inc.ALNY$140$2M-93.75%
Jun 29, 2020Jun 30, 2020Paul Steven M
Pres
amp; CEO
SellKaruna Therapeutics, Inc.KRTX$103.5$30M-73.29%
Feb 10, 2020Feb 11, 2020Paul Steven M
Dir
SellAlnylam Pharmaceuticals, Inc.ALNY$130$4M-96.77%
Jun 28, 2019Jul 02, 2019Paul Steven M
Pres
CEO
BuyKaruna Therapeutics, Inc.KRTX$23.04$230,424+50.00%
Mar 21, 2019Mar 22, 2019Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$161.04$1M-1.20%
Mar 18, 2019Mar 21, 2019Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$161.28$10M-3.58%
Feb 25, 2019Feb 27, 2019Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$161$322,000-0.16%
Feb 15, 2019Feb 20, 2019Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$161.04$8M-4.14%
Mar 06, 2018Mar 08, 2018Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$172$10M-8.42%
Jan 14, 2016Jan 15, 2016Paul Steven M
Pres
CEO
BuyVoyager Therapeutics, Inc.VYGR$14.07$140,690+1.13%
Sep 01, 2015Sep 02, 2015Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$52.41$1M-2.84%
Aug 03, 2015Aug 04, 2015Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$67.08$1M-2.76%
Jul 01, 2015Jul 02, 2015Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$69.4$1M-2.69%
Jun 01, 2015Jun 02, 2015Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$72.34$1M-2.62%
May 01, 2015May 05, 2015Paul Steven M
Dir
SellSage Therapeutics, Inc.BFAM$53.31$1M-2.55%
Apr 01, 2015Apr 02, 2015Paul Steven M
Dir
SellSage Therapeutics, Inc.SAGE$48.51$970,200-2.49%
Jan 26, 2015Jan 28, 2015Paul Steven M
Dir
BuyAlnylam Pharmaceuticals, Inc.ALNY$95$95,000+50.00%
Jul 23, 2014Jul 23, 2014Paul Steven M
Dir
BuySage Therapeutics, Inc.SAGE$18$180,000+1.23%